Western Health Advantage
Lorbrena (lorlatinib)
Drugs for Cancer : Drugs for Cancer
  • Diabetes Type 2: GLP1 + Combo:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Supporting Documentation Requirements: Medication History

  • Quantity Limit: 30 day supply per 1 fill(s).
  • PA_APPLIES
  • Quantity Limit: 4 capsules per day